Unity Biotechnology, Inc. (UNBX)
OTCMKTS · Delayed Price · Currency is USD
0.0878
+0.0078 (9.75%)
At close: Aug 25, 2025
Unity Biotechnology Market Cap
Unity Biotechnology has a market cap or net worth of $1.51 million as of August 26, 2025. Its market cap has decreased by -93.94% in one year.
Market Cap
1.51M
Enterprise Value
7.19M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.09
Market Cap Chart
Since May 3, 2018, Unity Biotechnology's market cap has decreased from 697.69M to 1.51M, a decrease of -99.78%. That is a compound annual growth rate of -56.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2025 | 1.51M | -90.81% |
| Dec 31, 2024 | 16.45M | -49.21% |
| Dec 29, 2023 | 32.39M | -16.69% |
| Dec 30, 2022 | 38.89M | -53.86% |
| Dec 31, 2021 | 84.28M | -69.60% |
| Dec 31, 2020 | 277.27M | -16.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 3, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 636.43M |
| Elite Pharmaceuticals | 587.83M |
| CytoDyn | 388.66M |
| American Oncology Network | 382.44M |
| Northwest Biotherapeutics | 357.21M |